Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF for chronic migraine
ACTRN12615001260516Phase 2Terminated
- Sponsor
- Cell-Innovations
- Start
- Aug 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic migraine comparing SVF with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Aug 2016; status: terminated.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
chronic migraine
Beyond the preview
Go deeper on ACTRN12615001260516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001260516.